CD46 and neoplasm: Similarly in a study by N.Geis et al., small interfering RNAs (siRNAs) have been designed for posttranscriptional gene knock down of CD46, CD55 and CD59 targeting tumor cells’ sensitization to complement attack and thus to further exploit complement for tumor cell destruction.